HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Henry Nasrallah Selected Research
Henry Nasrallah Research Topics
Disease
9
Schizophrenia (Dementia Praecox)
01/2022 - 01/2008
4
Psychotic Disorders (Schizoaffective Disorder)
10/2019 - 03/2006
2
Parkinson Disease (Parkinson's Disease)
10/2019 - 12/2018
2
Diabetes Mellitus
01/2007 - 03/2006
1
Toothache (Toothaches)
01/2022
1
Treatment-Resistant Depressive Disorder
08/2018
1
Neurobehavioral Manifestations
07/2013
1
Weight Gain
05/2011
1
Type 2 Diabetes Mellitus (MODY)
01/2007
1
Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
01/2007
1
Dyslipidemias (Dyslipidemia)
03/2006
Drug/Important Bio-Agent (IBA)
8
Antipsychotic Agents (Antipsychotics)
IBA
10/2019 - 03/2006
3
pimavanserin
IBA
01/2022 - 12/2018
2
Quetiapine Fumarate (Seroquel)
FDA Link
12/2018 - 05/2011
2
Risperidone (Risperdal Consta)
FDA Link
Generic
05/2011 - 01/2007
2
Olanzapine (Zyprexa)
FDA Link
05/2011 - 01/2007
2
Pharmaceutical Preparations
IBA
12/2009 - 01/2007
1
Aripiprazole (Abilify)
FDA Link
01/2019
1
cariprazine
IBA
01/2019
1
Clozapine (Clozaril)
FDA Link
Generic
12/2018
1
Buprenorphine (Subutex)
FDA Link
Generic
08/2018
1
(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanone
IBA
01/2017
1
Dextroamphetamine (Dexedrine)
FDA Link
Generic
10/2013
1
Lisdexamfetamine Dimesylate
FDA Link
10/2013
1
Prodrugs
IBA
10/2013
1
Dopamine (Intropin)
FDA Link
Generic
07/2013
1
ziprasidone (Geodon)
FDA Link
05/2011
1
Cholesterol
IBA
05/2011
1
Perphenazine (Trilafon)
FDA Link
Generic
05/2011
1
Triglycerides (Triacylglycerol)
IBA
05/2011
1
Brain-Derived Neurotrophic Factor (BDNF)
IBA
05/2010
1
Nerve Growth Factor (NGF)
IBA
12/2009
1
Nerve Growth Factors (Neurotrophins)
IBA
12/2009
1
Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)
IBA
01/2008
1
Glucose (Dextrose)
FDA Link
Generic
01/2007
Therapy/Procedure
1
Aftercare (After-Treatment)
01/2022
1
Therapeutics
10/2013
1
Secondary Prevention
06/2010